Welcome
Support Centre
21 November 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A cluster randomised trial evaluating the clinical effectiveness and cost of telemedicine delivered multidisciplinary meetings in breast cancer
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN67592929
Date ISRCTN assigned11/11/2005
Local reference number(s)1217319
Public titleA cluster randomised trial evaluating the clinical effectiveness and cost of telemedicine delivered multidisciplinary meetings in breast cancer
Scientific title
AcronymTELEMAM
Disease/condition/study domainBreast cancer.
Study hypothesisDecision making in breast cancer management at a multidisciplinary team (MDT) meeting is as clinically effective as face-to-face meetings and achieved at lower cost.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaEligibility of patients:
1. Histologically proven breast cancer
2. Requiring decision on treatment of primary or recurrent breast cancer
Participants - exclusion criteriaNot defined.
Patient information material
Anticipated start date24/04/2003
Anticipated end date31/07/2005
Status of trialCompleted
Target number of participants230
InterventionsRandomised standard face-to-face 'on site' multidisciplinary meetings for breast cancer management (MDTs) at Dumfries and Dunfermline (Arm 1) versus MDTs on Dumfries and Dunfermline patients linked by telemedicine between Dumfries and Edinburgh, and Dunfermline and Edinburgh (Arm 2).
Primary outcome measure(s)1. Satisfaction with communication process of multidisciplinary decision making for each patient (Interpersonal Communication Satisfaction Scale)
2. Costs of face-to-face and telemedicine delivered decision making
3. Compliance with Scottish Intercollegiate Guidelines Network (SIGN) guidelines of best practice for breast cancer
Secondary outcome measure(s)1. Pre- and post-trial attitudes to face-to-face and telemedicine delivered multidisciplinary clinics (Personal Report of Communication Apprehension)
2. Measures of objective patterns of interaction
3. Subjective measures of interaction (Group Behaviour Questionnaire, Group Behaviour Inventory, Group Dimensions Description Questionnaire)
4. Communication content (Interaction Process Analysis)
5. General dimensions of output (satisfaction with communication, group atmosphere, involvement, trust and agreement)
PublicationsKunkler IH, Fielding RG, Brebner J, Prescott R, Maclean R, Cairns J, Chetty U, Neades G, Walls A, Bowman A, Dixon JM, Gardner T, Smith M, McCoubrey J, Lee M, Swann S, Macnab M, Wilson J, Nawroz I: A comprehensive approach for evaluating telemedicine delivered multidisciplinary breast cancer meetings in Southern Scotland. <I>Telemed & eHealth ’04: Citizen-Centred Care</I>. RSM, London, 29 November 2004.
Sources of fundingDepartment of Health Research and Development
Big Lottery Fund
Sponsor nameUK Department of Health Research and Development
Sponsor detailsDr R Curry and Mr W Maton-Howarth
Department of Health Research and Development
Richmond House
79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)207 210 4850
Sponsor fax+44 (0)207 210 5025
Sponsor emailrichard.curry@imperial.ac.uk
Sponsor websitehttp://www.dh.gov.uk
Contact nameDr Ian Kunkler
Contact detailsOncology Department
Western General Hospital
Crewe Road South
Edinburgh
United Kingdom
EH4 2XU
Contact telephone+44 (0)131 537 2213
Contact fax+44 (0)131 537 2216
Contact emailiankunkler@yahoo.com
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN67592929
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central